Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction

Clinical trial NCT00047346 · COMPLETED

Trial details

NCT number: NCT00047346
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer

Start date: 2002-08-01
Primary completion: 2005-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.